PMID- 11245924 OWN - NLM STAT- MEDLINE DCOM- 20010628 LR - 20190826 IS - 0169-328X (Print) IS - 0169-328X (Linking) VI - 87 IP - 2 DP - 2001 Mar 5 TI - 9-cis-Retinoic acid represses transcription of the gonadotropin-releasing hormone (GnRH) gene via proximal promoter region that is distinct from all-trans-retinoic acid response element. PG - 214-22 AB - We previously reported an enhancing effect of all-trans-retinoic acid (all-trans-RA) on gonadotropin-releasing hormone (GnRH) gene transcription via distal promoter elements of the rat GnRH gene. The present study examined the effects of another biologically active retinoid, 9-cis-retinoic acid (9-cis-RA), on GnRH transcription in GT1-1 cells. Similar to the action of all-trans-RA, 9-cis-RA significantly induced the luciferase activity of the strong retinoic acid response element (RARE) reporter construct, 3X beta RARE-Luc, by about 60-fold, indicating that GT1-1 cells are also responsive to 9-cis-RA. In contrast to the stimulatory effect of all-trans-RA on GnRH transcription, 9-cis-RA inhibited the GnRH promoter activity in a dose- and time-dependent manner. Significant inhibition by 9-cis-RA required at least an 18 h treatment and a further decrease of GnRH promoter-driven luciferase activity was observed up to 48 h of incubation. Accordingly, GnRH mRNA levels were decreased by 9-cis-RA treatment in a similar dose- and time-related manner, indicating that mouse GnRH expression is also negatively regulated by 9-cis-RA. Transient transfections of serial deletion constructs of the rat GnRH promoter revealed that the --230/--110 sequence of the rat GnRH promoter is responsible for 9-cis-RA-induced inhibition of GnRH transcription. Within this region, however, no consensus retinoid X receptor response element was found. To gain insights into the role of retinoid X receptors (RXRs) in GnRH expression, we examined the effects of RXR overexpression on GnRH transcriptional activity. Interestingly, co-transfection of RXR overexpression vectors significantly increased the GnRH promoter-driven luciferase activity, while treatment with 9-cis-RA not only nullified the enhancing effect of RXR overexpression but also decreased the basal GnRH promoter-driven luciferase activity by 50% compared to vehicle-treated controls. This implies that RXRs in the absence of its cognate ligand 9-cis-RA contribute to the maintenance of basal GnRH gene transcription. Northern blot analysis revealed that 9-cis-RA, but not all-trans-RA, down-regulated RXR beta expression in GT1-1 cells, suggesting that one possible mechanism of 9-cis-RA-induced repression involves down-regulation of RXR expression. In conclusion, the present study clearly demonstrates that 9-cis-RA is a negative regulator of GnRH gene expression in immortalized GnRH neurons. FAU - Cho, S AU - Cho S AD - School of Biological Sciences and Research Center for Cell Differentiation, Seoul National University, Seoul, 151-742, South Korea. FAU - Chung, J AU - Chung J FAU - Han, J AU - Han J FAU - Ju Lee, B AU - Ju Lee B FAU - Han Kim, D AU - Han Kim D FAU - Rhee, K AU - Rhee K FAU - Kim, K AU - Kim K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - Brain Res Mol Brain Res JT - Brain research. Molecular brain research JID - 8908640 RN - 0 (Antineoplastic Agents) RN - 0 (Ligands) RN - 0 (RNA, Messenger) RN - 0 (Receptors, Retinoic Acid) RN - 0 (Retinoid X Receptors) RN - 0 (Transcription Factors) RN - 1UA8E65KDZ (Alitretinoin) RN - 33515-09-2 (Gonadotropin-Releasing Hormone) RN - 5688UTC01R (Tretinoin) SB - IM MH - Alitretinoin MH - Animals MH - Antineoplastic Agents/*pharmacology MH - Cells, Cultured MH - Dose-Response Relationship, Drug MH - Gene Expression Regulation/drug effects/physiology MH - Gonadotropin-Releasing Hormone/*genetics/metabolism MH - Ligands MH - Promoter Regions, Genetic/*genetics MH - RNA, Messenger/metabolism MH - Rats MH - Receptors, Retinoic Acid/metabolism MH - Retinoid X Receptors MH - Transcription Factors/metabolism MH - Transcription, Genetic/drug effects/physiology MH - Transfection MH - Tretinoin/*pharmacology EDAT- 2001/03/14 10:00 MHDA- 2001/06/29 10:01 CRDT- 2001/03/14 10:00 PHST- 2001/03/14 10:00 [pubmed] PHST- 2001/06/29 10:01 [medline] PHST- 2001/03/14 10:00 [entrez] AID - S0169328X01000201 [pii] AID - 10.1016/s0169-328x(01)00020-1 [doi] PST - ppublish SO - Brain Res Mol Brain Res. 2001 Mar 5;87(2):214-22. doi: 10.1016/s0169-328x(01)00020-1.